AnaptysBio, Inc. ANAB Acquired in-process research and development expenses
Acquired in-process research and development expenses at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff.
The official record: AnaptysBio, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s acquired in-process research and development expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s acquired in-process research and development expenses?
- AnaptysBio, Inc. (ANAB) reported acquired in-process research and development expenses of $0 in Q4 2025.
- What does acquired in-process research and development expenses mean?
- This metric represents the costs incurred to acquire intellectual property or research projects from third parties that have not yet reached technological feasibility. It reflects the company's strategy of supplementing internal innovation with external assets to accelerate the development pipeline. Monitoring this helps investors assess the capital intensity and risk profile of the company's inorganic growth strategy.